83053-38-7 Usage
Heterocyclic compound
2-(2-Hydroxyphenyl)thiazole consists of a ring structure containing both carbon and hetero atoms (N, O, S), classifying it as a heterocyclic compound.
Thiazole derivative
The compound contains a thiazole ring, which is a five-membered ring with one sulfur atom and one nitrogen atom, making it a derivative of thiazole.
Hydroxyphenyl group attachment
A hydroxyphenyl group is attached to the second position of the thiazole ring, influencing the compound's chemical properties and reactivity.
Pharmaceutical and biological activities
2-(2-Hydroxyphenyl)thiazole has potential pharmaceutical and biological activities, such as anti-inflammatory and anti-tumor properties.
Drug development and medicinal chemistry
The compound has been studied for its use in drug development and medicinal chemistry due to its unique structure and properties.
Research target
The structure and properties of 2-(2-Hydroxyphenyl)thiazole make it a target for research in the development of new pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 83053-38-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,0,5 and 3 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 83053-38:
(7*8)+(6*3)+(5*0)+(4*5)+(3*3)+(2*3)+(1*8)=117
117 % 10 = 7
So 83053-38-7 is a valid CAS Registry Number.
83053-38-7Relevant articles and documents
HERBICIDAL COMPOUNDS
-
Page/Page column 41, (2020/06/01)
The present invention relates to compounds of Formula (I) or an agronomically acceptable salt of said compounds wherein Q, R1, R2, n and m are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.
Compounds enhancing antitumor activity of other cytotoxic agents
-
, (2008/06/13)
This invention relates to certain heterocyclic compounds and their pharmaceutically acceptable salts, which are useful for sensitizing multidrug-resistant tumor cells to anticancer agents and multidrug resistant forms of malaria, tuberculosis, leishmania and amoebic dysentery to chemotherapeutants. The compounds and their pharmaceutically acceptable salts are also inhibitors of the active drug transport capability of P-glycoprotein which is encoded by the human MDR1 gene, as well as of certain other related ATP-binding-cassette transporters from eukaryotic and prokaryotic organisms (e.g., pfmdr from Plasmodium falciprum, and murine mdr1 and mdr3 gene products).
